Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia.
High KP, Case D, Hurd D, Powell B, Lesser G, Falsey AR, Siegel R, Metzner-Sadurski J, Krauss JC, Chinnasami B, Sanders G, Rousey S, Shaw EG. High KP, et al. Among authors: hurd d. J Support Oncol. 2012 Sep-Oct;10(5):195-201. doi: 10.1016/j.suponc.2011.10.005. Epub 2012 Jan 23. J Support Oncol. 2012. PMID: 22266154 Free PMC article. Clinical Trial.
Phase I study of lenalidomide in solid tumors.
Miller AA, Case D, Harmon M, Savage P, Lesser G, Hurd D, Melin SA. Miller AA, et al. Among authors: hurd d. J Thorac Oncol. 2007 May;2(5):445-9. doi: 10.1097/01.JTO.0000268679.33238.67. J Thorac Oncol. 2007. PMID: 17473661 Free article. Clinical Trial.
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.
Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G. Lamar ZS, et al. Among authors: hurd d. Leuk Lymphoma. 2018 Aug;59(8):1871-1877. doi: 10.1080/10428194.2017.1410889. Epub 2017 Dec 18. Leuk Lymphoma. 2018. PMID: 29252084 Free PMC article.
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.
Pardee TS, Lee K, Luddy J, Maturo C, Rodriguez R, Isom S, Miller LD, Stadelman KM, Levitan D, Hurd D, Ellis LR, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL. Pardee TS, et al. Among authors: hurd d. Clin Cancer Res. 2014 Oct 15;20(20):5255-64. doi: 10.1158/1078-0432.CCR-14-1019. Epub 2014 Aug 27. Clin Cancer Res. 2014. PMID: 25165100 Free PMC article. Clinical Trial.
The transplant iron score as a predictor of stem cell transplant survival.
Storey JA, Connor RF, Lewis ZT, Hurd D, Pomper G, Keung YK, Grover M, Lovato J, Torti SV, Torti FM, Molnár I. Storey JA, et al. Among authors: hurd d. J Hematol Oncol. 2009 Oct 24;2:44. doi: 10.1186/1756-8722-2-44. J Hematol Oncol. 2009. PMID: 19852846 Free PMC article.
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
Lamar ZS, Fino N, Palmer J, Gruber L, Morris BB, Raetskaya-Solntseva O, Kennedy L, Vaidya R, Hurd D, Zamkoff K. Lamar ZS, et al. Among authors: hurd d. Clin Lymphoma Myeloma Leuk. 2016 Feb;16(2):76-81. doi: 10.1016/j.clml.2015.11.012. Epub 2015 Dec 2. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26725264 Free PMC article.
215 results